Decreased cerebral 5-HT1A receptors during ageing: reversal by Ginkgo biloba extract (EGb 761)
- PMID: 8051617
- DOI: 10.1111/j.2042-7158.1994.tb03802.x
Decreased cerebral 5-HT1A receptors during ageing: reversal by Ginkgo biloba extract (EGb 761)
Abstract
Investigation of [3H]8-hydroxy-2(di-n-propylamino)tetralin binding to 5-HT1A receptors in cerebral cortex membranes of Wistar rats showed that the maximal number of binding sites (Bmax) was reduced significantly (22%) in aged (24-month-old) as compared with young (4-month-old) animals. Chronic treatment with Ginkgo biloba extract did not alter binding in young rats but increased binding density significantly (33%) in aged rats. These results confirm previously described age-related 5-hydroxytryptaminergic alterations. Together with data in the literature, they also suggest a restorative effect in aged rats, associated with decreased receptor density resulting from the protective action of Ginkgo biloba extract treatment on neuronal membrane.
Similar articles
-
Stress-induced 5-HT1A receptor desensitization: protective effects of Ginkgo biloba extract (EGb 761).Fundam Clin Pharmacol. 1995;9(2):169-74. doi: 10.1111/j.1472-8206.1995.tb00277.x. Fundam Clin Pharmacol. 1995. PMID: 7628830
-
Alpha 2-adrenoceptor changes during cerebral ageing. The effect of Ginkgo biloba extract.J Pharm Pharmacol. 1992 Jan;44(1):24-7. doi: 10.1111/j.2042-7158.1992.tb14357.x. J Pharm Pharmacol. 1992. PMID: 1350623
-
Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.J Neurochem. 1994 May;62(5):1822-34. doi: 10.1046/j.1471-4159.1994.62051822.x. J Neurochem. 1994. PMID: 8158133
-
[3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.J Neurochem. 1986 Jan;46(1):68-75. doi: 10.1111/j.1471-4159.1986.tb12926.x. J Neurochem. 1986. PMID: 2933490
-
Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia.Life Sci. 1991;48(4):355-63. doi: 10.1016/0024-3205(91)90556-q. Life Sci. 1991. PMID: 1824956
Cited by
-
Current Naturopathy to Combat Alzheimer's Disease.Curr Neuropharmacol. 2023;21(4):808-841. doi: 10.2174/1570159X20666220927121022. Curr Neuropharmacol. 2023. PMID: 36173068 Free PMC article. Review.
-
Plasma membrane and brain dysfunction of the old: Do we age from our membranes?Front Cell Dev Biol. 2022 Oct 6;10:1031007. doi: 10.3389/fcell.2022.1031007. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36274849 Free PMC article. Review.
-
The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex.Br J Pharmacol. 2010 Feb 1;159(3):659-68. doi: 10.1111/j.1476-5381.2009.00580.x. Epub 2010 Jan 25. Br J Pharmacol. 2010. PMID: 20105177 Free PMC article.
-
Ginkgo biloba induced mood dysregulation: a case report.BMC Complement Altern Med. 2018 Jan 15;18(1):14. doi: 10.1186/s12906-018-2081-4. BMC Complement Altern Med. 2018. PMID: 29334964 Free PMC article.
-
Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer's Dementia: Clinical Trial Systematic Review.Antioxidants (Basel). 2024 May 27;13(6):651. doi: 10.3390/antiox13060651. Antioxidants (Basel). 2024. PMID: 38929090 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical